That progression — if progress it is — provides the framework for the varied array of specimens in the show.
A spreadsheet supported, 5-year (87 cycles), three-state (progression free, progressed, and death) Markov model 14, 17 was developed in Microsoft Excel® 2003 (version 11, Microsoft Corporation, Redmond, WA, USA) to compare cost and quality adjusted life years (QALYs) of nab-paclitaxel versus conventional paclitaxel.
A Markov model with progression-free, progressed, and dead states was developed to estimate costs, outcomes, and quality adjusted life years over 5 years from the Italian National Health Service viewpoint.
Health outcomes and costs were modeled using a Markov cohort model with four health states: progression free survival, progressed survival with supportive care, progressed survival with 2nd-line chemotherapy and death.
In their learning progression, students cyclically progress from the scaffolded minimal levels (e.g., student makes a claim and backs it with sufficient and appropriate evidence with scaffolding) to un-scaffolded complex levels (e.g., student makes a claim, backs it up with evidence, and provides reasoning to tie the two together).
In patients with CA-125 first progression who subsequently progressed radiologically, a delay of 2.3 months was observed between the two progression types.
In the staged-progression model, individuals progress through disease stages with different infectivities, which represent the acute, latent, and AIDS stages of HIV infection.
Of the five patients treated at MTD and assessed for response, one patient had stable disease for 5.5 months before disease progression; the others progressed within 1 2 months.
Although increasing ACR or decreasing eGFR predicts CAC progression, coronary atherosclerosis progresses faster in people with type 1 diabetes even in the absence of diabetic kidney disease.
Workers showed an age-dependent progression of activity, progressing from tasks such as nursing and grooming in the nest to outside tasks such as walking and foraging.
